A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

Clinical trial NCT06710847 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06710847
Sponsor: GlaxoSmithKline
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neoplasms, Colorectal Solid Tumor Colon Cancer Rectal Cancer Endometrial Cancer

Start date: 2024-12-13
Primary completion: 2026-06-22
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.